Xudong Chen

522 total citations
21 papers, 348 citations indexed

About

Xudong Chen is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xudong Chen has authored 21 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 10 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xudong Chen's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (5 papers). Xudong Chen is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (5 papers). Xudong Chen collaborates with scholars based in China, Denmark and Singapore. Xudong Chen's co-authors include Yuwen Du, Guoqiang Zhao, Wenqiao Zang, Yuanyuan Wang, Litao Zhang, Fuqing Wang, Guohua Song, Ziming Dong, Li Li and Min Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The FASEB Journal.

In The Last Decade

Xudong Chen

21 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xudong Chen China 12 222 203 79 63 42 21 348
Yong Du China 12 285 1.3× 243 1.2× 115 1.5× 57 0.9× 30 0.7× 23 425
Shan Liu China 12 252 1.1× 239 1.2× 66 0.8× 44 0.7× 49 1.2× 34 376
Zhiyuan Qin China 9 321 1.4× 210 1.0× 100 1.3× 59 0.9× 44 1.0× 15 418
Gaofeng Li China 9 224 1.0× 151 0.7× 64 0.8× 32 0.5× 57 1.4× 27 326
Esther Redín Spain 12 175 0.8× 111 0.5× 128 1.6× 72 1.1× 70 1.7× 19 337
Yu-Feng Yang China 9 283 1.3× 137 0.7× 51 0.6× 51 0.8× 57 1.4× 16 356
Sze Keong Tey Hong Kong 12 294 1.3× 217 1.1× 75 0.9× 120 1.9× 67 1.6× 19 447
Ju-Chen Yen Taiwan 12 329 1.5× 263 1.3× 50 0.6× 38 0.6× 72 1.7× 22 481
Xinguang Cao China 9 236 1.1× 188 0.9× 94 1.2× 80 1.3× 40 1.0× 23 369
Meina Yan China 12 256 1.2× 154 0.8× 49 0.6× 55 0.9× 24 0.6× 18 365

Countries citing papers authored by Xudong Chen

Since Specialization
Citations

This map shows the geographic impact of Xudong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xudong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xudong Chen more than expected).

Fields of papers citing papers by Xudong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xudong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xudong Chen. The network helps show where Xudong Chen may publish in the future.

Co-authorship network of co-authors of Xudong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xudong Chen. A scholar is included among the top collaborators of Xudong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xudong Chen. Xudong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xudong, et al.. (2024). High Expression of NLR and SII in patients With Nasopharyngeal Carcinoma as Potential Prognostic Observations. Cancer Control. 31. 2925706154–2925706154. 3 indexed citations
2.
3.
Qi, Shasha, Jinyu Zhu, Linda Liang, et al.. (2023). The roles and mechanisms of SREBP1 in cancer development and drug response. Genes & Diseases. 11(4). 100987–100987. 28 indexed citations
4.
Wang, Weiguo, et al.. (2022). HYOU1 promotes cell proliferation, migration, and invasion via the PI3K/AKT/FOXO1 feedback loop in bladder cancer. Molecular Biology Reports. 50(1). 453–464. 8 indexed citations
5.
Jing, Qing, et al.. (2022). LINC00240 knockdown inhibits nasopharyngeal carcinoma progress by targeting miR‐26a‐5p. Journal of Clinical Laboratory Analysis. 36(5). e24424–e24424. 7 indexed citations
6.
Chen, Xudong, et al.. (2022). The employment of vaccinia virus for colorectal cancer treatment: A review of preclinical and clinical studies. Human Vaccines & Immunotherapeutics. 18(6). 2143698–2143698. 8 indexed citations
7.
Chen, Xudong, et al.. (2021). LncRNA FEZF1-AS1 accelerates the migration and invasion of laryngeal squamous cell carcinoma cells through miR-4497 targeting GBX2. European Archives of Oto-Rhino-Laryngology. 278(5). 1523–1535. 8 indexed citations
8.
Chen, Xudong, et al.. (2020). Long non-coding RNA AB073614 promotes metastasis of gastric cancer cells by upregulating IGF-2. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Zhao, Wei, Ying Xu, Meixiao Zhan, et al.. (2020). Circulating tumor DNA as a potential prognostic and predictive biomarker during interventional therapy of unresectable primary liver cancer. Journal of Gastrointestinal Oncology. 11(5). 1065–1077. 19 indexed citations
10.
Chen, Weihao, Xudong Chen, Yurong Wang, et al.. (2019). Construction and Analysis of lncRNA-Mediated ceRNA Network in Cervical Squamous Cell Carcinoma by Weighted Gene Co-Expression Network Analysis. Medical Science Monitor. 25. 2609–2622. 14 indexed citations
11.
Zhuang, Wu, Junxun Ma, Xudong Chen, et al.. (2018). The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-cancer-gene Panel. Journal of Cancer. 9(13). 2302–2307. 20 indexed citations
12.
Chen, Xudong, et al.. (2018). MicroRNA-4497 functions as a tumor suppressor in laryngeal squamous cell carcinoma via negatively modulation the GBX2. Auris Nasus Larynx. 46(1). 106–113. 18 indexed citations
13.
Chen, Xudong, et al.. (2017). ARK5 promotes invasion and migration in hepatocellular carcinoma cells by regulating epithelial-mesenchymal transition. Oncology Letters. 15(2). 1511–1516. 7 indexed citations
14.
Zhu, Xinghua, Yaxun Wu, Xiaobing Miao, et al.. (2016). High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma. Tumor Biology. 37(11). 14615–14628. 40 indexed citations
15.
Guo, Wentao, Fei Wang, Yanjie You, et al.. (2015). miR-1291 targets mucin 1 inhibiting cell proliferation and invasion to promote cell apoptosis in esophageal squamous cell carcinoma. Oncology Reports. 34(5). 2665–2673. 31 indexed citations
16.
Chen, Xudong, Guoqiang Zhao, Fuqing Wang, et al.. (2014). Upregulation of miR-513b inhibits cell proliferation, migration, and promotes apoptosis by targeting high mobility group-box 3 protein in gastric cancer. Tumor Biology. 35(11). 11081–11089. 31 indexed citations
17.
Zang, Wenqiao, Yuanyuan Wang, Yuwen Du, et al.. (2013). Differential expression profiling of microRNAs and their potential involvement in esophageal squamous cell carcinoma. Tumor Biology. 35(4). 3295–3304. 28 indexed citations
18.
Zheng, Shangen, Yuwen Du, Heying Chu, et al.. (2013). Analysis of MAT3 gene expression in NSCLC. Diagnostic Pathology. 8(1). 166–166. 15 indexed citations
19.
Zhang, Rui, Min Li, Wenqiao Zang, et al.. (2013). MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2. Tumor Biology. 35(1). 837–844. 48 indexed citations
20.
Chen, Xudong, et al.. (2011). Downregulation of SOK1 promotes the migration of MCF-7 cells. Biochemical and Biophysical Research Communications. 407(2). 389–392. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026